The investigation by Glancy Prongay & Murray LLP into potential violations of state laws by Dynavax's directors and officers could lead to legal challenges or penalties. Such developments often result in negative investor sentiment, potentially leading to a decline in stock price. The high relevance and importance are due to the direct focus on Dynavax and the potential legal and financial implications.